Clinical Trial Update: LFMT vs Placebo in New Biologic Start for Ulcerative Colitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LFMT versus placebo as a new biologic treatment for ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• LFMT

Snippet

Sponsor: University of Alberta | Conditions: Ulcerative Colitis | Phase 2 | Status: RECRUITING